Currently out of the existing stock ratings of Bing Zhao, 2 are a BUY (100%).

Bing Zhao

Work Performance Price Targets & Ratings Chart

Analyst Bing Zhao, currently employed at CHINA RENAISSANCE, has had 100% of price targets met with an average potential upside of 88.55%, reached in 201 days on average. Previously, Bing Zhao worked at STIFEL.

Bing Zhao has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on IMAB, I-Mab at 08-Jul-2021.

Wall Street Analyst Bing Zhao

Analyst best performing recommendations are on IMAB (I-MAB).
The best stock recommendation documented was for IMAB (I-MAB) on 2/11/2020. The price target of $17.93 was fulfilled within 78 days with a profit of $6.75 (60.38%), with a performance score of 7.74.

Average potential price target upside

IMAB I-Mab

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-Sep-2025

$9

$9

1 years 29 days ago
(24-Oct-2025)

0/3 (0%)

$4.78 (113.27%)

Buy Since 02-Nov-2021

$6

$6

1 years 2 months 14 days ago
(08-Sep-2025)

4/10 (40%)

$1.73 (40.52%)

44

Buy Since 09-Jul-2025

$7

$7

1 years 3 months 1 days ago
(21-Aug-2025)

0/2 (0%)

$2.29 (48.62%)

Buy Since 07-Dec-2020

$7

1 years 4 months 26 days ago
(27-Jun-2025)

2/7 (28.57%)

$4.63 (195.36%)

59

Buy Since 25-Feb-2021

$8

$10

2 years 2 months 6 days ago
(16-Sep-2024)

3/5 (60%)

$6.94 (654.72%)

373

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Bing Zhao?

On 2020
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?